Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Aptevo Therapeutics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 10 | 18 | +8 |
| Shares | 2.64K | 1.96M | +1.96M (+74,199.8%) |
| Value | $12.4K | $599.1K | +$586.7K (+4,733.3%) |
New holders (9)
Institutions that held Aptevo Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 749,234 | $229.3K | 0.01% |
| Sabby Management, LLC | 501,499 | $153.5K | 2.04% |
| Hudson Bay Capital Management LP | 500,000 | $153.0K | 0.00% |
| UBS Group AG | 115,910 | $35.5K | 0.00% |
| HRT Financial LP | 30,560 | $9.00K | 0.00% |
| Geode Capital Management, LLC | 19,385 | $5.93K | 0.00% |
| Baader Bank INC | 20,152 | $5.02K | 0.00% |
| Virtu Financial LLC | 17,395 | $5.00K | 0.00% |
| Bank of America Corp | 160 | $49 | 0.00% |
Sold out (1)
Institutions that held Aptevo Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Truvestments Capital LLC | 2 | $9 |